Exercise and Use of Enhancement Drugs at the Time of the COVID-19 Pandemic: A Multicultural Study on Coping Strategies During Self-isolation and Related Risks

Artemisa Dores, Irene Carvalho, Julius Burkauskas, Pierluigi Simonato, Ilaria De Luca, Roisin Mooney, Konstantinos Ioannidis, M. Angeles Gomez-Martinez, Zsolt Demetrovics, Krisztina Edina Abel, Attila Szabo, Hironobu Fujiwara , Mami Shibata, Alejandro Rebeca Melero Ventolo , Eva Maria Arroyo-Anllo, Ricardo M Santos-Labrador, Inga Griskova-Bulanova, Aiste Pranckeviciene, Kei Koboyashi, Giovanni MartinottiNaomi Fineberg, Fernando Barbosa, Ornella Corazza

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
23 Downloads (Pure)

Abstract

Introduction: Little is known about the impact of restrictive measures during the COVID-19 pandemic on self-image and engagement in exercise and other coping strategies alongside the use of image and performance-enhancing drugs (IPEDs) to boost performance and appearance. Objectives: To assess the role of anxiety about appearance and self-compassion on the practice of physical exercise and use of IPEDs during lockdown. Methods: An international online questionnaire was carried out using the Exercise Addiction Inventory (EAI), the Appearance Anxiety Inventory (AAI), and the Self-Compassion Scale (SCS) in addition to questions on the use of IPEDs.

Results: The sample consisted of 3,161 (65% female) adults from Italy (41.1%), Spain (15.7%), the United Kingdom (UK) (12.0%), Lithuania (11.6%), Portugal (10.5%), Japan (5.5%), and Hungary (3.5%). The mean age was 35.05 years (SD = 12.10). Overall, 4.3% of the participants were found to engage in excessive or problematic exercise with peaks registered in the UK (11.0%) and Spain (5.4%). The sample reported the use of a wide range of drugs and medicines to boost image and performance (28%) and maintained use during the lockdown, mostly in Hungary (56.6%), Japan (46.8%), and the UK (33.8%), with 6.4% who started to use a new drug. Significant appearance anxiety levels were found across the sample, with 18.1% in Italy, 16.9% in Japan, and 16.7% in Portugal. Logistic regression models revealed a strong association between physical exercise and IPED use. Anxiety about appearance also significantly increased the probability of using IPEDs. However, self-compassion did not significantly predict such behavior. Anxiety about appearance and self-compassion were non-significant predictors associated with engaging in physical exercise.

Discussion and Conclusion: This study identified risks of problematic exercising and appearance anxiety among the general population during the COVID-19 lockdown period across all the participating countries with significant gender differences. Such behaviors were positively associated with the unsupervised use of IPEDs, although no interaction between physical exercise and appearance anxiety was observed. Further considerations are needed to explore the impact of socially restrictive measures among vulnerable groups, and the implementation of more targeted responses.
Original languageEnglish
Article number648501
Number of pages17
JournalFrontiers in Psychiatry
Volume12
DOIs
Publication statusPublished - 10 Mar 2021

Keywords

  • body dysmorphic disorders
  • body image
  • compulsive exercise
  • obsessive-compulsive disorder
  • performance-enhancing substances

Fingerprint

Dive into the research topics of 'Exercise and Use of Enhancement Drugs at the Time of the COVID-19 Pandemic: A Multicultural Study on Coping Strategies During Self-isolation and Related Risks'. Together they form a unique fingerprint.

Cite this